SUSAN SIPES: Open Payments
NPI 1801335591 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,460 in 126 payments from 18 companies in 2025. Trend: 2023 $2,146 · 2024 $2,332 · 2025 $2,460
Food & beverage: $2,460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $539 |
| ANI Pharmaceuticals, Inc. | 18 | $487 |
| Boston Scientific Corporation | 26 | $372 |
| Collegium Pharmaceutical, Inc. | 12 | $167 |
| MML US, Inc. | 3 | $144 |
| PFIZER INC. | 11 | $136 |
| Lundbeck LLC | 5 | $110 |
| Neurocrine BioSciences, Inc. | 4 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| IBSA Pharma Inc. | 2 | $74 |
Products named: PURIFIED CORTROPHIN GEL, QULIPTA, WaveWriter Alpha Prime 16, Belbuca, UBRELVY, ReActiv8, NURTEC ODT, VYEPTI.
Industry payments across IN — which companies pay providers there.
